Royal Bank of Canada’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Royal Bank of Canada’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,770	Closed	-$36K	–	8190
2022 Q3	$36K	Sell	1,770 -47,872	-96%	-$631K	﹤0.01%	5909
2022 Q2	$342K	Buy	49,642 +47,556	+2,280%	+$334K	﹤0.01%	4377
2022 Q1	$19K	Sell	2,086 -4,456	-68%	-$47.4K	﹤0.01%	6648
2021 Q4	$93K	Buy	6,542 +2,771	+73%	+$47.9K	﹤0.01%	6004
2021 Q3	$88K	Sell	3,771 -56,058	-94%	-$1.33M	﹤0.01%	5803
2021 Q2	$1.49M	Sell	59,829 -99,432	-62%	-$2.67M	﹤0.01%	3317
2021 Q1	$4.46M	Buy	159,261 +45,469	+40%	+$1.64M	﹤0.01%	2326
2020 Q4	$3.97M	Buy	+113,792	New	+$4.95M	﹤0.01%	2347

Royal Bank of Canada's FMTX Position: Q4 2022 in Review

Royal Bank of Canada sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 1,770 shares — an estimated $36K sold.

Royal Bank of Canada first reported a position in FMTX in Q4 2020 and held it in 8 quarters. The position peaked at $4.46M in Q1 2021. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Royal Bank of Canada reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Royal Bank of Canada sold 1,770 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $36K.
Royal Bank of Canada first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
Royal Bank of Canada's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $4.46M in Q1 2021.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Royal Bank of Canada's 13F filing for Q4 2022, filed 14 Feb 2023.